# Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate

> **NCT03134846** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 79 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Margin Assessment

## Interventions

- **DRUG:** Cetuximab-IRDye800CW

## Key facts

- **NCT ID:** NCT03134846
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-16
- **Primary completion:** 2021-12
- **Final completion:** 2022-06
- **Target enrollment:** 79 (ESTIMATED)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03134846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03134846, "Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03134846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*